Complete loss of the atrial natriuretic peptide-converting enzyme Corin and CHAF-LA syndrome: Implications to natriuretic peptide physiology and left atrium health

Keywords

ANP / atrial natriuretic peptide / atriopathy / Corin

References

[1] Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol [Internet] 2020;17(11):698-717. Available from:

[2] Bie P. Natriuretic peptides and normal body fluid regulation. Compr Physiol 2018;8(3):1211-1249.

[3] Capri Y, Kwon T, Boyer O, et al. Biallelic NPR1 loss of function variants are responsible for neonatal systemic hypertension. J Med Genet 2023;60(10):993-998.

[4] Baris Feldman H, Chai Gadot C, Zahler D, et al. Corin and left atrial cardiomyopathy, hypertension, arrhythmia, and fibrosis. N Engl J Med 2023;389(18):1685-1692.

[5] Chan JCY, Knudson O, Wu F, Morser J, Dole WP, Wu Q. Hypertension in mice lacking the proatrial natriuretic peptide convertase Corin [Internet]. 2005 [cited 2020 Jun 22]. Available from:

[6] Lasco G, Mendoza J, Renedo A, et al. Nasa dugo (It's in the blood’): Lay conceptions of hypertension in the Philippines. BMJ Glob Heal 2020;5(7):1-8.

[7] Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: The DECAAF study. Jama 2014;311(5):498-506.

[8] Van Den Berg MP, Mulder BA, Klaassen SHC, et al. Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis. Eur Heart J 2019;40(16):1287-1293.

[9] Donnellan E, Wazni OM, Hanna M, et al. Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 2020;6(9):1118-1127.

[10] Sullivan RD, Houng AK, Gladysheva IP, et al. Corin overexpression reduces myocardial infarct size and modulates cardiomyocyte apoptotic cell death. Int J Mol Sci 2020;21(10):3456.

[11] Cannone V, Burnett JC. Natriuretic peptides and blood pressure homeostasis: implications for MANP, a novel guanylyl cyclase a receptor activator for hypertension. Front Physiol 2022;12(February):1-8.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.